ATE336261T1 - Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen - Google Patents
Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungenInfo
- Publication number
- ATE336261T1 ATE336261T1 AT02723117T AT02723117T ATE336261T1 AT E336261 T1 ATE336261 T1 AT E336261T1 AT 02723117 T AT02723117 T AT 02723117T AT 02723117 T AT02723117 T AT 02723117T AT E336261 T1 ATE336261 T1 AT E336261T1
- Authority
- AT
- Austria
- Prior art keywords
- factor xiii
- platele
- disorders
- treatment
- blood clotting
- Prior art date
Links
- 229940012444 factor xiii Drugs 0.000 title abstract 3
- 239000003114 blood coagulation factor Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 108010071289 Factor XIII Proteins 0.000 abstract 2
- 206010043554 thrombocytopenia Diseases 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27047001P | 2001-02-21 | 2001-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE336261T1 true ATE336261T1 (de) | 2006-09-15 |
Family
ID=23031445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02723117T ATE336261T1 (de) | 2001-02-21 | 2002-02-07 | Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1387691B1 (de) |
| JP (1) | JP2004537505A (de) |
| AT (1) | ATE336261T1 (de) |
| CA (1) | CA2438763A1 (de) |
| DE (1) | DE60213968T2 (de) |
| ES (1) | ES2268017T3 (de) |
| WO (1) | WO2002067981A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008510476A (ja) | 2004-08-27 | 2008-04-10 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 生物学的材料からのｘｉｉｉ因子ポリペプチドの精製 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2037664T3 (es) * | 1985-11-26 | 1993-07-01 | Novo Nordisk A/S | Composiciones y metodos para el tratamiento de trastornos hemorragicos. |
| US5612456A (en) * | 1988-11-14 | 1997-03-18 | Zymogenetics, Inc. | Factor XIII compositions |
| US5622988A (en) * | 1990-06-15 | 1997-04-22 | Novo Nordisk A/S | Use of a low molecular weight metabolite from fungus for reducing prolonged coagulation time |
| AU3423493A (en) * | 1991-12-31 | 1993-07-28 | Zymogenetics Inc. | Methods and compositions for reducing blood loss |
| ATE184199T1 (de) * | 1992-11-12 | 1999-09-15 | Zymogenetics Inc | Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen |
-
2002
- 2002-02-07 DE DE60213968T patent/DE60213968T2/de not_active Expired - Lifetime
- 2002-02-07 EP EP02723117A patent/EP1387691B1/de not_active Expired - Lifetime
- 2002-02-07 CA CA002438763A patent/CA2438763A1/en not_active Abandoned
- 2002-02-07 JP JP2002567346A patent/JP2004537505A/ja active Pending
- 2002-02-07 AT AT02723117T patent/ATE336261T1/de not_active IP Right Cessation
- 2002-02-07 ES ES02723117T patent/ES2268017T3/es not_active Expired - Lifetime
- 2002-02-07 WO PCT/US2002/003770 patent/WO2002067981A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002067981A1 (en) | 2002-09-06 |
| JP2004537505A (ja) | 2004-12-16 |
| EP1387691B1 (de) | 2006-08-16 |
| CA2438763A1 (en) | 2002-09-06 |
| DE60213968D1 (de) | 2006-09-28 |
| DE60213968T2 (de) | 2007-08-30 |
| EP1387691A1 (de) | 2004-02-11 |
| ES2268017T3 (es) | 2007-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE468137T1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| DE60113548D1 (de) | Cyanomethyl-substituierte thiazolium- und imidazolium-verbindungen und behandlung von erkrankungen im zusammenhang mit proteinalterung | |
| ATE254461T1 (de) | Behandlung von augenschmerzen | |
| DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| CY1109650T1 (el) | Χρηση νευρικων νηματικων πρωτεϊνων για την αντιμετωπιση νεοπλασιων | |
| ATE154758T1 (de) | Levobupivacain nützlich zur behandlung von chronischen schmerzen | |
| DE69929464D1 (de) | Zyklische polyamine zur behandlung der thrombozytopenie | |
| DE60100625D1 (de) | Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina | |
| ATE390928T1 (de) | Zusammensetzungen zur behandlung von hauterkrankungen | |
| ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
| EP1056458A4 (de) | Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen | |
| ATE336261T1 (de) | Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen | |
| DE60033569D1 (de) | Neue verwendung von prodigiosin zur behandlung von diabetes mellitus | |
| ATE506947T1 (de) | Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen | |
| ATE337004T1 (de) | Verwendung von mangafodipir zur behandlung der hepatozellularen insuffizienz | |
| DE60128084D1 (de) | Verwendung von inaktives cln2 proenzym zur behandlung von lincl | |
| EP1143996A4 (de) | Methode zur behandlung von chronischen herzerkrankungen | |
| ATE360437T1 (de) | Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a | |
| DE69928814D1 (de) | Verwendung von tgf-beta inhibitoren zur behandlung von cerebralen krankheiten | |
| ATE382367T1 (de) | Behandlung des typ 1 diabetes vor und nach expression von prädispositionsmarkern | |
| ATE230608T1 (de) | Verwendung von bradykinin-antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimer'schen krankheit | |
| DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
| ATE214923T1 (de) | Verwendung von (r)-verapamil als medizin zur behandlung von angina | |
| DE60129599D1 (de) | Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |